The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835698/ #Ivermectic
PubMed Central (PMC)
The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug
Drug repositioning is a highly studied alternative strategy to discover and develop anticancer drugs. This drug development approach identifies new indications for existing compounds. Ivermectin belongs to the group of avermectins (AVM), a series of 16-membered…